Skip to main content
. 2020 Jul 4;19:100809. doi: 10.1016/j.ajoc.2020.100809

Table 2.

Comparison of visual light sensitivity Questionnaire-8 (VLSQ-8) pre/post botulinum toxin A injection.

Patient 1 Patient 2 Patient 3 Patient 4
Q1. In the past month, how often did you have visual light sensitivity outdoors during daylight? Pre 5 5 4 4
Post 3 3 3 2
Q2. In the past month, how often did you have a sense of glare in your eyes? Pre 5 5 4 3
Post 2 3 3 2
Q3. In the past month, how often did you have visual light sensitivity from flickering lights or bright colors? Pre 3 5 4 4
Post 2 3 4 2
Q4. Please rate the severity of the worst visual light sensitivity you experienced in the past month. Pre 5 5 5 4
Post 3 3 4 3
Q5. When you have sensitivity to light, do you also experience headache? Pre 1 5 3 3
Post 1 3 3 2
Q6. When you have sensitivity to light, how often is your vision blurry? Pre 1 5 2 2
Post 1 2 1 2
Q7. How often does sensitivity to light limit your ability to read, watch TV, or use the computer? Pre 5 5 4 4
Post 5 3 2 3
Q8. In the past month, how often did you need to wear dark glasses on cloudy days or indoors? Pre 5 5 4 2
Post 5 3 1 2
Total VLSQ-8 (scale 8–40) Pre 30 40 30 26
Post 22 23 21 18

All questions except Question 4 were answered as 1 (never), 2 (rarely), 3 (sometimes), 4 (often), or 5 (always). Question 4 was answered from 1 to 5 with 1 as none, 3 as moderate, and 5 as severe.